Matthew Barber, MD, MHS, MSOD is the Senior Vice President for Ambulatory Services and Physician Practices of DUHS, President of Duke Health Integrated Practice (DHIP), and Vice Dean for Clinical Affairs in the Duke School of Medicine. Barber oversees the ambulatory enterprise and physician practices across DHIP, Duke Primary Care, hospital-based clinics, and Duke’s Population Health Management Organization, with responsibility for systemwide ambulatory strategy and operations, integrated governance, and aligned practice standards. Across these entities, Duke Health’s ambulatory platform includes more than 3,000 clinicians and 18 clinical departments practicing in DUHS hospitals and more than 250 primary and specialty clinics across North Carolina.

Barber was the W. Allen Addison Distinguished Professor and the Chair of the Department of Obstetrics and Gynecology at Duke University Medical Center from 2017-2025. From 2018-2022, he also served as the Chief of the Medical Staff of Duke University Hospital. Known for his dedication to connecting faculty and staff to mission, Barber recently served as an executive sponsor of Duke Health’s culture transformation work to become “Better Together,” and spearheads change through action in his daily interactions.

Barber earned his medical degree from Jefferson Medical College of Thomas Jefferson University, a master’s degree in Health Science in Clinical Research from Duke University School of Medicine, and a master’s degree in Positive Organizational Development and Change from Case Weatherhead School of Management. Barber completed his residency training in obstetrics and gynecology and a fellowship in urogynecology and pelvic reconstructive surgery at Duke University. Before rejoining Duke, Barber spent 16 years at the Cleveland Clinic in various leadership roles.

Barber's clinical practice encompasses the full spectrum of diagnosis, prevention and medical, behavioral, and surgical treatments for women with pelvic floor disorders (PFDs). His research focuses on conducting randomized clinical trials for the treatment of gynecologic conditions, particularly surgical trials for PFDs. He is an internationally recognized expert in developing, validating, and assessing research outcomes in PFDs, particularly health-related quality of life and patient-reported outcomes. Barber has served on the Board of Directors of the American Urogynecologic Society from 2008-2013 and as its President from 2011-2012. He is a Director of the American Board of Obstetrics and Gynecology (2021-2024; 2025- 2028) and the co-editor of the 5th and 6th editions of Walter & Karram Urogynecology and Reconstructive Pelvic Surgery.